Pharmafile Logo
Pharmafocus logo
Advanced Search

T cell

Showing 8 posts of 8 posts found.

29419203133_3c3c14e63e_z

Cardiff University team discovers new method of killing cancers

January 21, 2020
Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell

A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …

News

T cells found to ‘acquire knowledge’ to take fight to metastatic cancer

May 17, 2017
Research and Development Cancer, T cell, immunotherapy

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …

News
adaptimmune_lab_scientists_growing_research_cells_jpg-web

Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial

August 4, 2016
Research and Development Adaptimmune, T cell, oncology, t-cell

Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …

News
jose_conejo-garcia_-_wistar_institute

Targeted cancer therapies can suppress T cell immune responses, study finds

March 23, 2016
Research and Development T cell, anti-cancer drugs, immunosuppresive, superagonist, wistar institute

Researchers at the Wistar Institute have developed a new method whereby targeted cancer therapies can provide appropriate therapeutics without supressing …

News
Merck Serono image

Merck Serono in $826m immuno-oncology deal

March 31, 2015
Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …

News
T cell image

UK makes £30m investment in T-Cell cancer therapy

January 22, 2015
Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …

News

Adaptimmune wins fund payout

March 26, 2014
Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme

Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

News

Tolerx to collaborate on first-in-class cancer antibody

December 2, 2010
Research and Development Cancer, T cell, Torelx, monoclonal antibody

US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …

News

Latest content

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023

AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial

September 22, 2023

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023